Work

Abstract P3-04-08: The role of HER2 mutations in resistance to endocrine therapy in ER+ breast cancer

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs16-p3-04-08

Authors: U Nayar, O Cohen, C Oh, N Wagle

Institutions: Broad Institute, Dana-Farber Cancer Institute

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2592058755

Cites:

Cited by:

Related to: 10